To further determine the necroptosis-promotive role of TRAF5 silencing on HCC cells, HepG2 and HuH7 cells were treated with sh-TRAF5 or/and the necroptosis inducer SHN. This evidence concerns the gene TRAF5 and hepatocellular carcinoma.